Tan Jin, Liu Shengzhong, Jiang Qin, Yu Tao, Huang Keli
Cardiovascular Surgery Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu 610000, China.
Cardiol Res Pract. 2019 Apr 16;2019:6280194. doi: 10.1155/2019/6280194. eCollection 2019.
To study the expression and clinical significance of long noncoding RNA- (lncRNA-) MIAT in patients with coronary atherosclerotic heart disease (CAD).
Serum MIAT, interleukin-6 (IL-6), and tumor necrosis factor- (TNF-) in 106 CAD patients and 89 healthy donors were detected. Correlations between serum MIAT and serum IL-6 and TNF- were analyzed. Risk factors for patients with CAD were analyzed by multiple factor analysis.
Compared with healthy donors, serum lncRNA-MIAT was significantly increased in CAD patients. Serum MIAT was positively correlated with serum IL-6 and TNF- in CAD. Multivariate analysis found that hypertension (OR (95% CI) = 3.471 (2.180-4.091), =0.011), diabetes (OR (95% CI) = 3.682 (1.698-4.897), =0.003), HDL-C (OR (95% CI) = 3.372 (1.760-6.920), =0.001), and serum MIAT expression (OR (95% CI) = 2.687 (1.683-7.468), =0.001) were independent risk factors for CAD.
Serum lncRNA-MIAT in CAD patients was significantly increased, which may be a potential marker for diagnosis and prognosis of CAD.
研究长链非编码RNA-(lncRNA-)心肌梗死相关转录本(MIAT)在冠状动脉粥样硬化性心脏病(CAD)患者中的表达及临床意义。
检测106例CAD患者和89例健康供者血清中的MIAT、白细胞介素-6(IL-6)和肿瘤坏死因子-(TNF-)。分析血清MIAT与血清IL-6和TNF-之间的相关性。采用多因素分析CAD患者的危险因素。
与健康供者相比,CAD患者血清lncRNA-MIAT显著升高。CAD患者血清MIAT与血清IL-6和TNF-呈正相关。多因素分析发现高血压(比值比(OR)(95%可信区间)=3.471(2.180-4.091),P=0.011)、糖尿病(OR(95%可信区间)=3.682(1.698-4.897),P=0.003)、高密度脂蛋白胆固醇(HDL-C)(OR(95%可信区间)=3.372(1.760-6.920),P=0.001)和血清MIAT表达(OR(95%可信区间)=2.687(1.683-7.468),P=0.001)是CAD的独立危险因素。
CAD患者血清lncRNA-MIAT显著升高,可能是CAD诊断和预后的潜在标志物。